Table 2 Number and percentage of NCI-funded implementation science research grants by study characteristics, fiscal years 2000-2012
Characteristic | Number of grants a | Percent of grants a |
|---|---|---|
Cancer control continuum | ||
Prevention | 33 | 49.3 |
Screening | 27 | 40.3 |
Diagnosis | 0 | 0.0 |
Treatment | 3 | 4.5 |
Survivorship | 4 | 6.0 |
Cross-cutting | 7 | 10.4 |
Types of cancer/risk factors | ||
Colorectal cancer | 20 | 29.9 |
Breast cancer | 12 | 17.9 |
Cervical cancer | 8 | 11.9 |
Tobacco | 26 | 38.8 |
Physical activity | 6 | 9.0 |
Diet/nutrition | 5 | 7.5 |
Sun safety | 5 | 7.5 |
Public health genomics | 4 | 6.0 |
Obesity | 3 | 4.5 |
Implementation science objectives | ||
Dissemination | 31 | 46.3 |
Adoption | 20 | 29.9 |
Implementation | 53 | 79.1 |
Sustainability | 26 | 38.8 |
Sustainability indicators | ||
Capacity building | 20 | 29.9 |
Maintenance | 25 | 37.3 |
Cost analysis | 15 | 22.4 |
Place on T2–T4 continuum | ||
T2 (efficacy studies) | 8 | 11.9 |
T3 (comparative effectiveness) | 61 | 91.0 |
T4 (outcomes research) | 8 | 11.9 |
Study settings | ||
Community | 18 | 26.9 |
Faith based | 3 | 4.5 |
School based | 6 | 9.0 |
Clinical | 35 | 52.2 |
Workplace | 10 | 14.9 |
Home based | 3 | 4.5 |
Online | 7 | 10.4 |
Collaborative processes | ||
Yes | 60 | 90 |
No | 7 | 10 |
Study design | ||
Experimental, randomized control trial | 39 | 58.2 |
Experimental, nonrandomized trial | 5 | 7.5 |
Observational | 21 | 31.3 |
Modeling | 2 | 3.0 |
Methods used | ||
Qualitative | 54 | 80.6 |
Quantitative | 59 | 88.1 |
Comparative effectiveness | 35 | 52.2 |
Cost analysis | 18 | 26.9 |
Simulation models | 2 | 3.0 |
Network analysis | 1 | 1.5 |
Frameworks/models | ||
RE-AIM | 23 | 34.3 |
Diffusion of Innovation | 26 | 38.8 |
Organizational Change | 7 | 10.4 |
Systems/Network Theories | 5 | 7.5 |
Chronic Care Models | 7 | 10.4 |
Model of Diffusion in Service Organizations | 3 | 4.5 |
How the model was used | ||
Intervention design | 48 | 71.6 |
Formative research | 22 | 32.8 |
Measured variables | 41 | 61.2 |
Only stated | 5 | 7.5 |
Replication costs considerations | ||
Yes | 33 | 49.3 |
No | 31 | 46.3 |
NA | 3 | 4.5 |